People use psilocybin mushrooms for a wide range of reasons: to treat depression and anxiety, to have spiritual or mystical experiences, to boost creativity and mood, to reduce their fear of death, to break addictions, or simply to alter their perception for a few hours. The motivations span from deeply clinical to purely recreational, and the growing body of research behind psilocybin has blurred the line between those categories in recent years.
The Mental Health Appeal
The most rapidly growing reason people turn to psilocybin is mental health. The FDA has granted breakthrough therapy designations for psilocybin in both treatment-resistant depression (2018) and major depressive disorder (2019), signaling that the agency considers it a potentially significant advance over existing treatments. In a phase 2 trial published in the New England Journal of Medicine, a single 25 mg dose of psilocybin reduced depression scores significantly more than a control dose over three weeks in people whose depression hadn’t responded to conventional antidepressants.
Psilocybin has also shown striking results for alcohol use disorder. In a clinical trial published in JAMA Psychiatry, people who received psilocybin-assisted therapy reported heavy drinking on only 9.7% of days over an eight-month period, compared to 23.6% in a control group. By the end of the study, nearly 48% of the psilocybin group was completely abstinent, versus about 24% in the control group. These numbers are notable because addiction is notoriously difficult to treat, and the benefits came from just a small number of psilocybin sessions paired with therapy.
What Psilocybin Does in the Brain
Once ingested, psilocybin converts into its active form, psilocin, which binds strongly to the same receptors that serotonin uses, particularly the 5-HT2A receptor. These receptors sit in brain regions that process sensory information, and when psilocin activates them, the normal filtering system quiets down. That’s why people experience visual distortions, a sense that sounds have color or texture, and a general loosening of the boundaries between senses.
The deeper neurological effect is a reshuffling of brain connectivity. Psilocybin breaks down the brain’s usual associative networks, the well-worn mental pathways that govern habitual thinking, and temporarily integrates perception networks that don’t normally communicate. Brain imaging studies show enhanced connectivity within the default mode network, the system active during self-reflection and mind-wandering. This disruption of rigid thought patterns is one reason researchers believe psilocybin helps with depression and addiction: it may give the brain a window to form new connections and escape repetitive, negative loops. The compound also stimulates neuroplasticity in the hippocampus and cortex, essentially encouraging brain cells to grow new connections.
Spiritual and Mystical Experiences
Long before clinical trials, people sought out psilocybin mushrooms for transcendent experiences. This remains one of the most commonly reported motivations. In a large study of over 1,400 people who had taken psilocybin, 88% reported having what qualifies as a mystical experience. Researchers have broken these experiences into four core dimensions: a sense of unity with something larger than yourself, intensely positive mood, the feeling that time and space have dissolved, and a quality of “ineffability,” meaning the experience feels impossible to put into words.
What makes this particularly interesting is that these experiences aren’t just fleeting. Studies from Johns Hopkins have shown that scores on mystical experience questionnaires taken during a psilocybin session predict lasting increases in personal well-being, life satisfaction, and positive behavior change at both one-month and 14-month follow-ups. For many users, a single powerful session becomes one of the most personally meaningful events of their lives, comparable to the birth of a child or the death of a parent.
Coping With the Fear of Death
One of the most compelling reasons people use psilocybin is to ease existential dread, particularly among those facing terminal illness. A randomized trial of 51 cancer patients with significant anxiety or depression found that a single high dose of psilocybin, given alongside supportive therapy, produced meaningful increases in death acceptance and decreases in death-related anxiety. About 90% of participants reported a decrease in their fear of death after the experience. The effects mirror what people who have had near-death experiences describe: a sense of peace, connection, and the feeling that consciousness extends beyond the physical body.
Creativity, Mood, and Microdosing
A substantial number of people use psilocybin mushrooms in tiny amounts, a practice called microdosing, typically aiming to sharpen focus, lift mood, or enhance creative thinking without producing any noticeable hallucinations. Surveys consistently find that microdosers report improved well-being, greater cognitive flexibility, increased empathy, and better problem-solving ability. Some use it to self-treat cluster headaches, depression, or anxiety.
The reality, however, is more complicated. When researchers put microdosing through rigorous double-blind, placebo-controlled testing, the benefits largely evaporated. A controlled study found that 0.5 grams of dried psilocybin mushrooms produced noticeable subjective effects (people could feel something), but had no measurable impact on creativity, cognition, physical activity, or mental health and well-being compared to placebo. Participants who correctly guessed they had received the real dose reported stronger effects than those who didn’t, suggesting that expectation and placebo response account for much of what microdosers experience. This doesn’t mean microdosing is worthless for everyone, but it does mean the enthusiastic testimonials circulating online should be taken with some skepticism.
Social Bonding and Recreation
Not every motivation is clinical or spiritual. Many people take mushrooms recreationally, for the sensory enhancement, the laughter, the feeling of deep connection with friends, or simply because the altered state of consciousness is interesting. Psilocybin increases sociality, imagination, and emotional openness, which is why group settings, whether at festivals, camping trips, or living rooms, are common contexts for use. Researchers studying the evolutionary role of psychedelics have identified enhanced social interaction and interpersonal bonding as one of four core reasons humans have used these substances throughout history, alongside managing psychological distress, facilitating collective ritual, and improving group decision-making.
What the Experience Feels Like
Effects typically begin 20 to 40 minutes after ingestion, peak at 60 to 90 minutes, and last a total of four to six hours. The experience is highly variable and depends on dose, personality, mood, expectations, and surroundings. At lower doses, people often describe enhanced colors, mild visual patterns, and a sense of emotional openness. At higher doses, the experience can include vivid hallucinations, a dissolving sense of self, and intense emotional states that range from euphoria to terror.
Unpleasant experiences, sometimes called “bad trips,” involve extreme fear, confusion, or panic and are a real risk. Physical side effects can include increased blood pressure and heart rate, nausea, headache, dizziness, and fatigue. Psilocybin is not safe for people with psychotic conditions like schizophrenia or severe bipolar disorder, as it can trigger or worsen psychotic episodes. There’s also the practical danger of misidentification: some poisonous mushrooms look nearly identical to psilocybin-containing species, and confusing them can be fatal. When obtained outside legal channels, mushrooms can also be adulterated with other substances.
In clinical settings, these risks are managed through careful screening, controlled doses, and the presence of trained therapists. Outside those settings, the unpredictability of the experience is both part of the appeal for some users and the primary source of harm for others.